Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Senzer

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Seminars in Oncology|February 11, 2003
A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findingsNeil Senzer
Seminars in Oncology|February 11, 2003
Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiationNeil Senzer
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2015
Shedding New Light on the Use of Imaging Technology for Glioblastoma Tumor ResectionJohn Nemunaitis, Neil Senzer
Current Opinion in Molecular Therapeutics|January 27, 2009
A review of contusugene ladenovec (Advexin) p53 therapyNeil Senzer, John Nemunaitis
Seminars in Oncology|January 17, 2004
Feasibility of amifostine administration in conjunction with high-dose rate brachytherapyTimothy Dziuk, Neil Senzer
Journal of Drug Delivery|June 2, 2012
Reversible masking using low-molecular-weight neutral lipids to achieve optimal-targeted deliveryNancy Smyth Templeton, Neil Senzer
Journal of Genetic Syndromes & Gene Therapy|October 23, 2012
Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated VesiclesNancy Smyth Templeton, Neil Senzer
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 26, 2003
Enhanced oncolytic potency of replicative adenovirus expressing p53John Nemunaitis, Casey Cunningham, Neil Senzer
Gene Regulation and Systems Biology|October 20, 2009
Letter to the editor: Does dicer expression affect shRNA processing?Neil Senzer, Donald Rao, John Nemunaitis
Annals of Translational Medicine|November 22, 2016
Tumor vaccines and cellular immunotherapiesJohn Nemunaitis, Neil Senzer, Leah Plato
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Seminars in Oncology|February 11, 2003
A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findingsNeil Senzer
Seminars in Oncology|February 11, 2003
Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiationNeil Senzer
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2015
Shedding New Light on the Use of Imaging Technology for Glioblastoma Tumor ResectionJohn Nemunaitis, Neil Senzer
Current Opinion in Molecular Therapeutics|January 27, 2009
A review of contusugene ladenovec (Advexin) p53 therapyNeil Senzer, John Nemunaitis
Seminars in Oncology|January 17, 2004
Feasibility of amifostine administration in conjunction with high-dose rate brachytherapyTimothy Dziuk, Neil Senzer
Journal of Drug Delivery|June 2, 2012
Reversible masking using low-molecular-weight neutral lipids to achieve optimal-targeted deliveryNancy Smyth Templeton, Neil Senzer
Journal of Genetic Syndromes & Gene Therapy|October 23, 2012
Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated VesiclesNancy Smyth Templeton, Neil Senzer
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 26, 2003
Enhanced oncolytic potency of replicative adenovirus expressing p53John Nemunaitis, Casey Cunningham, Neil Senzer
Gene Regulation and Systems Biology|October 20, 2009
Letter to the editor: Does dicer expression affect shRNA processing?Neil Senzer, Donald Rao, John Nemunaitis
Annals of Translational Medicine|November 22, 2016
Tumor vaccines and cellular immunotherapiesJohn Nemunaitis, Neil Senzer, Leah Plato
Pageof 8